 SAN JOSE, Dec. 04, 2020 GLOBE NEWSWIRE -- Anpac Bio-Medical Science Co., Ltd. Anpac Bio, the Company or we ANPC, a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today the resignation of Ernst Young Hua Ming LLP EY, which previously was the independent registered public accounting firm of Anpac Bio, on November 3, 2020 and the appointment of Friedman LLP Friedman as the Companys independent registered public accounting firm on December 2, 2020 to conduct the audit for the fiscal year ended December 31, 2020. The appointment of Friedman has been approved by both the audit committee and the board of directors the Board of the Company. The change was not made due to any disagreements with EY. 